AI Insight
This Lancet Perspectives piece reports on the immediate consequences of the suspension of USAID programs following President Trump's second inauguration in January 2025. The suspension disrupted essential medicine supply chains, halted payment systems, stopped clinical trials, and closed outreach programs for vulnerable populations. By November 2025, an estimated 600,000 people, approximately two-thirds of them children, had died as a result of these disruptions, according to Boston University epidemiologist Brooke Nichols.
Why it matters
The article highlights the critical dependence of global health systems on USAID funding and the rapid, life-threatening consequences when such support is abruptly withdrawn. It underscores the vulnerability of healthcare infrastructure in regions reliant on international aid and the immediate human cost of policy decisions affecting foreign development assistance.
Understand the Science
Within hours of Donald Trump’s second inauguration as US President in January, 2025, he suspended programmes supported by the US Agency for International Development (USAID). At once, supply chains for essential medicines snarled up, payment systems stopped functioning, desperately needed medical equipment sat in warehouses, clinical trials came to a halt, and outreach projects that ensured vulnerable people received care were closed. By November, estimates Boston University epidemiologist Brooke Nichols, about 600 000 people, two-thirds of them children, had died as a result.